Literature DB >> 2555072

Metabolic activation of hydroquinone by macrophage peroxidase.

M J Schlosser1, G F Kalf.   

Abstract

Lysates from macrophages, cells involved in hematopoiesis and immunological responses, catalyzed the metabolic activation of the benzene metabolite, hydroquinone, to protein-binding compounds and to free 1,4-benzoquinone. This reaction is mediated by a peroxidase since activation was dependent upon H2O2 and was prevented by the inhibitors aminotriazole and azide. Activation of hydroquinone was independent of HO. radicals since protein binding occurred in the presence of the HO. scavengers mannitol and dimethyl sulfoxide. In reactions with macrophage lysates, phenol, another hepatic metabolite of benzene, stimulated the production of 1,4-benzoquinone as well as the amount of hydroquinone equivalents bound to protein in a dose-dependent manner. Addition of cysteine to incubations with macrophage lysates resulted in a dose-dependent decrease in hydroquinone equivalents bound to protein. At 100 microM cysteine, protein binding was inhibited by 63% and this decrease was recovered as the monocysteine-hydroquinone conjugate. Macrophages catalyzed the arachidonic acid-mediated activation of hydroquinone to metabolites which bound to cellular macromolecules. This activation was inhibited by indomethacin indicating the action of prostaglandin synthase in hydroquinone metabolism by macrophages. The results of these experiments demonstrate that macrophage peroxidase catalyzes the metabolic oxidation of hydroquinone to 1,4-benzoquinone and that 1,4-benzoquinone and/or its semiquinone intermediate are binding to protein and cysteine. Hydroquinone activation by macrophages and subsequent macromolecular binding may be associated with the immunologic and hematopoietic toxicity of benzene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555072     DOI: 10.1016/0009-2797(89)90027-6

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Developmental hazard assessment with FETAX: aerobic metabolites in bacterial transformation of naphthalene.

Authors:  T W Schultz; D A Dawson
Journal:  Bull Environ Contam Toxicol       Date:  1995-05       Impact factor: 2.151

2.  A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process.

Authors:  R Niculescu; G F Kalf
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites.

Authors:  G Lévay; W J Bodell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

4.  Induction of granulocytic differentiation in a mouse model by benzene and hydroquinone.

Authors:  B A Hazel; A O'Connor; R Niculescu; G F Kalf
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

Review 5.  An overview of benzene metabolism.

Authors:  R Snyder; C C Hedli
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

6.  Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene.

Authors:  A M Hutt; G F Kalf
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

7.  p-Benzoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 alpha and -1 beta to active cytokines by inhibition of the processing enzymes, calpain, and interleukin-1 beta converting enzyme.

Authors:  G F Kalf; J F Renz; R Niculescu
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

8.  p-Benzoquinone initiates non-invasive urothelial cancer through aberrant tyrosine phosphorylation of EGFR, MAP kinase activation and cell cycle deregulation: Prevention by vitamin C.

Authors:  Shinjini Ganguly; Ayan Chandra; Dhruba J Chattopadhyay; Indu B Chatterjee
Journal:  Toxicol Rep       Date:  2017-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.